SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Cell Therapeutics (CTIC)
An SI Board Since August 1997
Posts SubjectMarks Bans Symbol
946 45 0 CTIC
Emcee:  Regis McConnell Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
821PIONEER Trial Interim Data to Provide Basis for Review Supported by Gender-SpeciIan@SI-6/1/2006
820Pix and Xyotax at ASCO next weekend... Cell Therapeutics, Inc. Announces ASCO AIan@SI-5/25/2006
819Pixantrone Produces High Rate (77 percent) of Complete Tumor Disappearance in Panigel bates-5/16/2006
818Item 1.01. Entry into a Material Definitive Agreement. Registered Offering of Icebrg-4/29/2006
817Item 1.01. Entry into a Material Definitive Agreement. [For supporting Dr BiancIcebrg-4/12/2006
816Cell Therapeutics, Inc. (CTI) Granted U.S. Patent for New Potent Antitubulin AgeIcebrg-4/10/2006
815Boy, talk about "toxic" converts....ugh! eomquidditch-4/6/2006
814Cell Therapeutics, Inc. (CTI) Announces Intention to Sell or Exchange a New SeriDoc Bones-4/6/2006
813I'll let kenhott speak for himself, but I feel Bianco is being a little wildtuck-3/22/2006
812Unfortunately most of my posts are not too clear. <These data suggest that ikenhott-3/22/2006
811Sorry but could you please explain your conclusion. Thanks.D.Lu-3/22/2006
810I have no useful comment about the data itself but Jim Bianco has learned nothinkenhott-3/22/2006
809Pixantrone Combination Regimen Produces High Rates of Complete Remission for PatIcebrg-3/22/2006
808Cell Therapeutics discloses probe info By Benjamin J. Romano Seattle Times busIcebrg-3/17/2006
807I sometimes wonder if we'll ever look back and marvel at what a glorious buytom pope-2/28/2006
806Cell Therapeutics, Inc. Hires Former BIO VP of Communications Tuesday February 2Icebrg-2/28/2006
805Cell Therapeutics boosts directors' compensation Cell Therapeutics Inc., coIcebrg-2/27/2006
804Cell Therapeutics says Xyotax has future Tue Feb 21, 2006 5:09 PM ET By Deena BeIcebrg-2/21/2006
803Thanks. That is an interesting table because the older women in the control arBiomaven-2/16/2006
802Peter, The only data available on Xyotax vs. control, that I have seen was presIcebrg-2/16/2006
801I wonder what the low estrogen vs normal estrogen results were in the control (nBiomaven-2/15/2006
800>>PGT202<< No control, right? Or am I missing something again? Ifkeokalani'nui-2/15/2006
799[Updated Xyotax PGT202 PII results] >>NEW YORK, Feb. 15 /PRNewswire-Firsttuck-2/15/2006
798I agree with Eric here. My point is that there is a basis for assuming a diffeBiomaven-2/10/2006
797Whoaa, not so fast. It is not the difference between men and women, that is the Icebrg-2/10/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News